Chronic treatment with the IDO1 inhibitor 1-methyl-D-tryptophan minimizes the behavioural and biochemical abnormalities induced by unpredictable chronic mild stress in mice - Comparison with fluoxetine

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Laugeray, Anthony ^a   Launay, Jean Marie ^b   Callebert, Jacques ^b   Mutlu, Oguz ^c,d   Guillemin, Gilles J ^e   Belzung, Catherine ^c   Barone, Pascal R ^c  

^a CNRS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d KOCAELI UNIVERSITY   (Turkey)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; FLUOXETINE; GAMMA INTERFERON; INDOXIMOD; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINE; QUINOLINIC ACID; TUMOR NECROSIS FACTOR; 1-METHYLTRYPTOPHAN; ANTIDEPRESSANT AGENT; AUTACOID; CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

AMYGDALA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BIOCHEMISTRY; BRAIN TISSUE; CHRONIC STRESS; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE RELEASE; DEPRESSION; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; GROOMING; LUNG PARENCHYMA; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PROTEIN BLOOD LEVEL; SYMPTOM; UNPREDICTABLE CHRONIC MILD STRESS; VALIDATION PROCESS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; CYTOKINES; DEPRESSION; FLUOXETINE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION MEDIATORS; KYNURENINE; MALE; MICE, INBRED BALB C; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TIME FACTORS; TRYPTOPHAN;

EID: 84994753656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164337     Document Type: Article

References (75)

1. Dantzer R, O'Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36: 426-436. doi: 10.1016/j.psyneuen.2010.09.012 PMID: 21041030
2. Myint AM (2012) Kynurenines: from the perspective of major psychiatric disorders. FEBS J 279: 1375-1385. doi: 10.1111/j.1742-4658.2012.08551.x PMID: 22404766
3. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13: 465-477. doi: 10.1038/nrn3257 PMID: 22678511
4. O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, et al. (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29: 4200-4209. doi: 10.1523/JNEUROSCI.5032-08.2009 PMID: 19339614
5. Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M (2005) IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 10: 538-544. doi: 10.1038/sj.mp.4001600 PMID: 15494706
6. Connor TJ, Starr N, O'Sullivan JB, Harkin A (2008) Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Neurosci Lett 441: 29-34. doi: 10.1016/j.neulet.2008.06.007 PMID: 18584961
7. Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C, et al. (1999) Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 116: 435-440. doi: 10.1046/j.1365-2249.1999.00910.x PMID: 10361231
8. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56. doi: 10.1038/nrn2297 PMID: 18073775
9. Remus JL, Dantzer R (2016) Inflammation models of depression in rodents: relevance to psychotropic drug discovery. Int J Neuropsychopharmacol.
10. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D (2006) Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364: 82-90. doi: 10.1016/j.cca.2005.06.013 PMID: 16139256
11. Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D (2000) Tryptophan degradation and immune activation in Alzheimer's disease. J Neural Transm 107: 343-353. doi: 10.1007/s007020050029 PMID: 10821443
12. Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S (2002) Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci 71: 1837-1848. PMID: 12175700
13. Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35: 298-306. PMID: 1943879
14. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D (2002) Neopterin production, tryptophan degradation, and mental depression - what is the link? Brain Behav Immun 16: 590-595. PMID: 12401473
15. Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, et al. (2014) Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr 65: 456-462. doi: 10.1097/QAI.0000000000000062 PMID: 24220289
16. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7: 468-473. doi: 10.1038/sj.mp.4000995 PMID: 12082564
17. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al. (2008) A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol 18: 230-233. doi: 10.1016/j.euroneuro.2007.06.004 PMID: 17681762
18. Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, et al. (2003) Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest 33: 550-554. PMID: 12814390
19. Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O'Connor JC (2013) Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 62: 202-209.
20. O'Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J, et al. (2009) Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182: 3202-3212. doi: 10.4049/jimmunol.0802722 PMID: 19234218
21. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, et al. (2008) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry.
22. Tavares RG, Schmidt AP, Abud J, Tasca CI, Souza DO (2005) In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine. Neurochem Res 30: 439-444. PMID: 16076013
23. Wu HQ, Pereira EF, Bruno JP, Pellicciari R, Albuquerque EX, Schwarcz R (2009) The Astrocyte-Derived alpha7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex. J Mol Neurosci.
24. Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7: 426-437. doi: 10.1038/nrd2462 PMID: 18425072
25. Skolnick P, Popik P, Trullas R (2009) Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 30: 563-569. doi: 10.1016/j.tips.2009.09.002 PMID: 19837463
26. Hashimoto K (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61: 105-123. doi: 10.1016/j.brainresrev.2009.05.005 PMID: 19481572
27. Santamaria A, Galvan-Arzate S, Lisy V, Ali SF, Duhart HM, Osorio-Rico L, et al. (2001) Quinolinic acid induces oxidative stress in rat brain synaptosomes. Neuroreport 12: 871-874. PMID: 11277599
28. Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70: 299-307. PMID: 9422375
29. Tan L, Yu JT (2012) The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations. J Neurol Sci 323: 1-8. doi: 10.1016/j.jns.2012.08.005 PMID: 22939820
30. Laugeray A, Launay JM, Callebert J, Surget A, Belzung C, Barone PR (2010) Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Behav Brain Res 210: 84-91. doi: 10.1016/j.bbr.2010.02.014 PMID: 20153778
31. Fuertig R, Azzinnari D, Bergamini G, Cathomas F, Sigrist H, Seifritz E, et al. (2016) Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase. Brain Behav Immun 54: 59-72. doi: 10.1016/j.bbi.2015.12.020 PMID: 26724575
32. Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, et al. (2008) Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 64: 293-301. doi: 10.1016/j.biopsych.2008.02.022 PMID: 18406399
33. Moreau M, Lestage J, Verrier D, Mormède C, Kelley KW, Dantzer R, et al. (2005) Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis 192: 537-544. doi: 10.1086/431603 PMID: 15995970
34. Laugeray A, Launay JM, Callebert J, Surget A, Belzung C, Barone PR (2011) Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences. Pharmacol Biochem Behav.
35. Mutlu O, Ulak G, Laugeray A, Belzung C (2009) Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice. Pharmacol Biochem Behav 92: 82-87. doi: 10.1016/j.pbb.2008.10.013 PMID: 19022280
36. Taher YA, Piavaux BJ, Gras R, van Esch BC, Hofman GA, Bloksma N, et al. (2008) Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. J Allergy Clin Immunol 121: 983-991 e982. doi: 10.1016/j.jaci.2007.11.021 PMID: 18179817
37. Willner P (2016) The chronic mild stress (CMS) model of depression: History, evaluation and usage. Neurobiology of Stress In press, Corrected Proof: 1-16.
38. Willner P (1997) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134: 319-329.
39. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, et al. (2002) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 99: 6370-6375. doi: 10.1073/pnas.092012099 PMID: 11959912
40. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. doi: 10.1126/science.1083328 PMID: 12907793
41. Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G, et al. (2009) Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 34: 1363-1380. doi: 10.1038/npp.2008.76 PMID: 18536703
42. Ducottet C, Aubert A, Belzung C (2004) Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice. Behav Brain Res 155: 291-299. doi: 10.1016/j.bbr.2004.04.020 PMID: 15364489
43. Isingrini E, Camus V, Le Guisquet AM, Pingaud M, Devers S, Belzung C (2010) Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS One 5: e10404. doi: 10.1371/journal.pone.0010404 PMID: 20436931
44. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90-110. doi: 10.1159/000087097 PMID: 16037678
45. Griebel G, Stemmelin J, Scatton B (2005) Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol Psychiatry 57: 261-267. doi: 10.1016/j.biopsych.2004.10.032 PMID: 15691527
46. Pothion S, Bizot JC, Trovero F, Belzung C (2004) Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155: 135-146. doi: 10.1016/j.bbr.2004.04.008 PMID: 15325787
47. Kalueff AV, Tuohimaa P (2004) Grooming analysis algorithm for neurobehavioural stress research. Brain Res Brain Res Protoc 13: 151-158. doi: 10.1016/j.brainresprot.2004.04.002 PMID: 15296852
48. Strekalova T, Spanagel R, Dolgov O, Bartsch D (2005) Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 16: 171-180. PMID: 15864072
49. Fava M, Rosenbaum JF (1999) Anger attacks in patients with depression. J Clin Psychiatry 60 Suppl 15: 21-24.
50. Asberg K (2013) Hostility/anger as a mediator between college students' emotion regulation abilities and symptoms of depression, social anxiety, and generalized anxiety. J Psychol 147: 469-490. doi: 10.1080/00223980.2012.715601 PMID: 24003591
51. Mineur YS, Prasol DJ, Belzung C, Crusio WE (2003) Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet 33: 513-519. PMID: 14574128
52. Paxinos G, Franklin K (2001) The Mouse Brain in Stereotoxic Coordinates. Academic Press: San Diego, CA.
53. Kema IP, Schellings AM, Hoppenbrouwers CJ, Rutgers HM, de Vries EG, Muskiet FA (1993) High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients. Clin Chim Acta 221: 143-158. PMID: 7512001
54. Fujigaki S, Saito K, Takemura M, Fujii H, Wada H, Noma A, et al. (1998) Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes. Arch Biochem Biophys 358: 329-335. doi: 10.1006/abbi.1998.0861 PMID: 9784247
55. Heyes MP, Markey SP (1988) Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem 174: 349-359. PMID: 2975477
56. Moroni F, Lombardi G, Carla V, Moneti G (1984) The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res 295: 352-355. PMID: 6231972
57. Ibarguen-Vargas Y, Surget A, Vourc'h P, Leman S, Andres CR, Gardier AM, et al. (2009) Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behav Brain Res 202: 245-251. doi: 10.1016/j.bbr.2009.03.040 PMID: 19463708
58. Ibarguen-Vargas Y, Surget A, Touma C, Palme R, Belzung C (2008) Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal. Psychoneuroendocrinology 33: 1357-1368. doi: 10.1016/j.psyneuen.2008.07.010 PMID: 18790573
59. Suzuki S, Tone S, Takikawa O, Kubo T, Kohno I, Minatogawa Y (2001) Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J 355: 425-429. PMID: 11284730
60. Gibney SM, Fagan EM, Waldron AM, O'Byrne J, Connor TJ, Harkin A (2014) Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. Int J Neuropsychopharmacol: 1-12.
61. Dobos N, de Vries EF, Kema IP, Patas K, Prins M, Nijholt IM, et al. (2011) The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression. J Alzheimers Dis.
62. Kiank C, Voss S, Starcke A, Zeden JP, domanska G, Fusch G, et al. (2009) Proinflammatory cytokines mediate acute stress-induced loss of intestinal barrier function in the terminal ileum which enhances tryptophan catabolism in BALB/C mice. Brain Behav Immun 22.
63. Kocki T, Wnuk S, Kloc R, Kocki J, Owe-Larsson B, Urbanska EM (2011) New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio. J Neural Transm.
64. Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C, et al. (2011) Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry.
65. Detanico BC, Piato AL, Freitas JJ, Lhullier FL, Hidalgo MP, Caumo W, et al. (2009) Antidepressant-like effects of melatonin in the mouse chronic mild stress model. Eur J Pharmacol 607: 121-125. doi: 10.1016/j.ejphar.2009.02.037 PMID: 19249298
66. Bano S, Morgan CJ, Badawy AA, Buckland PR, Guffin PM (1999) Inhibition of rat liver tryptophan pyrrolase activity by fluoxetine. Pak J Pharm Sci 12: 11-16. PMID: 16414828
67. Bano S, Sherkheli MA (2003) Inhibition of tryptophan - pyrrolase activity and elevation of brain tryptophan concentration by fluoxetine in rats. J Coll Physicians Surg Pak 13: 5-10. doi: 01.2003/JCPSP.0510 PMID: 12685966
68. Sherkheli MA, Bano S (2003) Similar pattern of inhibition of tryptophan pyrrolase activity by fluoxetine hydrochloride in both sexes of rats. Pak J Pharm Sci 16: 51-58.
69. Rice JM, Kovatch RM, Anderson LM (1989) Intraperitoneal mesotheliomas induced in mice by a polycyclic aromatic hydrocarbon. J Toxicol Environ Health 27: 153-160. doi: 10.1080/15287398909531285 PMID: 2724365
70. Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D, et al. (2014) Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U S A 111: 16136-16141. doi: 10.1073/pnas.1415191111 PMID: 25331895
71. Murakami Y, Hoshi M, Hara A, Takemura M, Arioka Y, Yamamoto Y, et al. (2012) Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection. Cytokine 59: 245-251. doi: 10.1016/j.cyto.2012.04.022 PMID: 22609210
72. Asp L, Johansson AS, Mann A, Owe-Larsson B, Urbanska EM, Kocki T, et al. (2011) Effects of proinflammatory cytokines on expression of kynurenine pathway enzymes in human dermal fibroblasts. J Inflamm (Lond) 8: 25.
73. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR (2012) A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26: 469-479. doi: 10.1016/j.bbi.2011.12.011 PMID: 22251606
74. Valera E, Ubhi K, Mante M, Rockenstein E, Masliah E (2014) Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia 62: 317-337. doi: 10.1002/glia.22610 PMID: 24310907
75. Lapin IP, Mutovkina LG, Ryzov IV, Mirzaev S (1996) Anxiogenic activity of quinolinic acid and kynurenine in the social interaction test in mice. J Psychopharmacol 10: 246-249. doi: 10.1177/026988119601000312 PMID: 22302953